OBJECTIVES: To investigate the presence of 4-1BB ligand (4-1BBL) in the peripheral blood of patients with allergic asthma and evaluate its role in controlling the balance between helper 17 T (Th17) and regulatory T (Treg) cells. METHODS: Soluble 4-1BBL (s4-1BBL) was quantified by enzyme-linked immunosorbent assay in plasma from patients with asthma (n = 45) and from healthy control subjects (n = 35). The proportion of monocytes positive for membrane-bound 4-1BBL (m4-1BBL) was determined by flow cytometry. Peripheral blood mononuclear cells from patients with asthma were incubated with anti-4-1BB monoclonal antibody in vitro. Concentrations of interleukin (IL)-17 and transforming growth factor (TGF)-β1 in the culture supernatant were analysed. RESULTS: Plasma s4-1BBL concentrations and the proportion of m4-1BBL-positive monocytes were significantly lower in patients with asthma than in control subjects. The culture supernatant concentration of TGF-β1 was increased and that of IL-17 was decreased by incubation with anti-4-1BB monoclonal antibody. CONCLUSIONS: Both soluble and membrane-bound 4-1BBL were reduced in patients with allergic asthma compared with control subjects. 4-1BBL/4-1BB signalling may play an important role in allergic asthma by regulating the Th17/Treg balance.
BatemanEDHurdSSBarnesPJ: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J2008; 31: 143–178.
2.
HolgateST: Novel targets of therapy in asthma. Curr Opin Pulm Med2009; 15: 63–71.
3.
MosmannTRCoffmanRL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol1989; 7: 145–173.
HolgateST: Pathogenesis of asthma. Clin Exp Allergy2008; 38: 872–897.
6.
TakahashiTTagamiTYamazakiS: Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med2000; 192: 303–310.
7.
ShimizuJYamazakiSTakahashiT: Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol2002; 3: 135–142.
8.
ShiYHShiGCWanHY: Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin Med J (Engl)2011; 124: 1951–1956.
9.
Al-RamliWPréfontaineDChouialiF: TH17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol2009; 123: 1185–1187.
10.
WakashinHHiroseKMaezawaY: IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med2008; 178: 1023–1032.
11.
ZhaoYYangJGaoYD: Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol2010; 151: 297–307.
12.
LeeSWVellaATKwonBS: Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J Immunol2005; 174: 6803–6808.
13.
MaertenPGeboesKDe HertoghG: Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease. Clin Immunol2004; 112: 239–246.
14.
LombardiVSinghAKAkbariO: The role of costimulatory molecules in allergic disease and asthma. Int Arch Allergy Immunol2010; 151: 179–189.
15.
ElpekKGYolcuESFrankeDD: Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol2007; 179: 7295–7304.
16.
DeBenedetteMAWenTBachmannMF: Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol1999; 163: 4833–4841.
17.
IrieJWuYKachapatiK: Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes. Diabetes2007; 56: 186–196.
18.
ChoYSKwonBLeeTH: 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Clin Exp Allergy2006; 36: 377–385.
19.
PolteTJagemannAFoellJ: CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-γ-producing CD8+ T cells. Clin Exp Allergy2007; 37: 1374–1385.
20.
TovarJMGumsJG: Monitoring pulmonary function in asthma and COPD: point-of-care testing. Ann Pharmacother2004; 38: 126–133.
21.
TurktasIHarmanciKBakirtasA: Diagnostic accuracy of skin-prick testing in young children with asthma. Pediatr Pulmonol2006; 41: 386–387.
22.
JuniperEFO'ByrnePMGuyattGH: Development and validation of a questionnaire to measure asthma control. Eur Respir J1999; 14: 902–907.
23.
PetersDChenCMarksonLE: Using an asthma control questionnaire and administrative data to predict health-care utilization. Chest2006; 129: 918–924.
24.
Van GanseEAntonicelliLZhangQ: Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med2006; 100: 140–147.
25.
SalihHRSchmetzerHMBurkeC: Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J Immunol2001; 167: 4059–4066.
26.
LiuGZGomesACPuthetiP: Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis. Scand J Immunol2006; 64: 412–419.
27.
KienzleGvon KempisJ: CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. Int Immunol2000; 12: 73–82.
28.
GoodwinRGDinWSDavis-SmithT: Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol1993; 23: 2631–2641.
29.
KwonB: CD137–CD137 ligand interactions in inflammation. Immune Netw2009; 9: 84–89.
30.
FoellJStrahotinSO'NeilSP: CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB × NZW F1 mice. J Clin Invest2003; 111: 1505–1518.
31.
SunYLinXChenHM: Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol2002; 168: 1457–1465.
32.
SunYBlinkSELiuW: Inhibition of Th2-mediated allergic airway inflammatory disease by CD137 costimulation. J Immunol2006; 177: 814–821.
33.
ZhengGWangBChenA: The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. J Immunol2004; 173: 2428–2434.
34.
SchabowskyRHElpekKGMadireddiS: A novel form of 4–1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity. Vaccine2009; 28: 512–522.
35.
KimYHChoiBKShinSM: 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells. J Immunol2011; 187: 1120–1128.
36.
IchiyamaKYoshidaHWakabayashiY: Foxp3 inhibits RORγt-mediated IL-17A mRNA transcription through direct interaction with RORγt. J Biol Chem2008; 283: 17003–17008.
